|
Volumn 66, Issue 8, 2006, Pages
|
Slowing down a "slow" movement disorder: Selegiline's benefit in treating Parkinson disease
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBIDOPA;
LEVODOPA;
MONOAMINE OXIDASE B INHIBITOR;
PLACEBO;
SELEGILINE;
CLINICAL TRIAL;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG MECHANISM;
DYSKINESIA;
HUMAN;
MOTOR DYSFUNCTION;
NAUSEA;
NOTE;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RATING SCALE;
SIDE EFFECT;
SYMPTOMATOLOGY;
UNIFIED PARKINSON DISEASE RATING SCALE;
WEARING OFF;
COMPARATIVE STUDY;
DRUG COMBINATION;
PATHOPHYSIOLOGY;
REVIEW;
DISEASE PROGRESSION;
DRUG THERAPY, COMBINATION;
HUMANS;
LEVODOPA;
PARKINSON DISEASE;
SELEGILINE;
|
EID: 33646693881
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000217547.43970.ea Document Type: Article |
Times cited : (1)
|
References (1)
|